Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
-156K
-
Total reported value, excl. options
-
$57.7M
-
Value change
-
-$447K
-
Put/Call ratio
-
0.03
-
Number of buys
-
39
-
Number of sells
-
-12
-
Price
-
$3.12
Significant Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q2 2023
66 filings reported holding GRTX - Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q2 2023.
Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
of 75.5M outstanding shares and own 24.51% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (3.08M shares), Novo Holdings A/S (2.1M shares), SECTORAL ASSET MANAGEMENT INC (2.01M shares), Alyeska Investment Group, L.P. (1.7M shares), Blackstone Inc. (1.68M shares), VANGUARD GROUP INC (1.43M shares), Velan Capital Investment Management LP (1M shares), Tekla Capital Management LLC (898K shares), Nan Fung Group Holdings Ltd (613K shares), and UBS OCONNOR LLC (571K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.